SFSIG
AMED

San Francisco Sentry Investment Group’s Amedisys AMED Stock Holding History

San Francisco Sentry Investment Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7
Closed -$1K – 948
2018
Q4 		$1K Buy
+7
New +$825 ﹤0.01% 808
2014
Q3 		– Sell
-6,300
Closed -$105K – 614
2014
Q2 		$105K Hold
6,300
– – 0.05% 218
2014
Q1 		$94K Hold
6,300
– – 0.03% 275
2013
Q4 		$92K Buy
6,300
+6,100
+3,050% +$98.2K 0.03% 261
2013
Q3 		$3K Hold
200
– – ﹤0.01% 578
2013
Q2 		$2K Buy
+200
New +$2.29K ﹤0.01% 612

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

San Francisco Sentry Investment Group's AMED Position: Q1 2019 in Review

San Francisco Sentry Investment Group sold out of Amedisys (AMED) in Q1 2019, closing a stake of 7 shares — an estimated $1K sold.

San Francisco Sentry Investment Group first reported a position in AMED in Q2 2013 and held it in 6 quarters. The position peaked at $105K in Q2 2014. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

  • San Francisco Sentry Investment Group reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 7 Amedisys shares in Q1 2019, an estimated $1K.
  • San Francisco Sentry Investment Group first reported a position in Amedisys in Q2 2013 and held it in 6 quarters.
  • San Francisco Sentry Investment Group's Amedisys position peaked at $105K in Q2 2014.
  • 317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2019, filed 8 May 2019.